Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 309
- Press releases
First Cancer Patients Treated With Apollon Formularies Products At The International Cancer and Chronic Pain Institute
Apollon Formularies Plc (AQSE: APOL) (“Apollon” or the “Company”), a UK based international medical cannabis pharmaceutical company trading on Aquis Stock Exchange, is pleased to announce that the International Cancer and Chronic Pain Institute is now officially open and has welcomed the first cancer patients to be treated with Apollon’s proprietary medical cannabis products.
- Pharmaceutical
London Stock Exchange Cannabis Company Values Down Almost £200m From Early Peaks
THIS has been a transformative year for the European cannabis industry, with growing liberalisation across the continent opening the floodgates for patients and investors alike.
- Your #1 Podcast on Cannabis News
Using a single-state model to drive focus and efficiencies
On this episode of BofC Live, we connect with Jeffrey Herold, CEO of Garden Remedies, a vertically integrated cannabis company operating in Massachusetts.
- Adult-Use
Why San Francisco cannabis retailers could get a tax break
To help cannabis stores compete with the illicit cannabis market, officials want to put a hold on a new tax on licensed retailers, reports NPR.
- Medical
First retail sales in Europe for vaporisation extracts completed
The first retail sales of extracts that can be used for vaporisation have been completed under the brand Naxiva-Panaxol.
- Uncategorized
How technology enables streamlined operations and compliance
Business of Cannabis was the Platinum Media Partner for the Lift&Co.
- Pharmaceutical
Global cannabinoid pharmaceuticals market to reach £1.53bn by 2025
The global cannabinoid pharmaceuticals market has been projected to reach £1.53bn (€1.8bn).
- Uncategorized
IM Cannabis führt die Marke WAGNERS in Deutschland ein
IM Cannabis rechnet damit, im Jahr 2022 hochwertiges, in Innenräumen angebautes kanadisches Cannabis in den sich schnell entwickelnden deutschen Markt für medizinisches Cannabis zu exportieren IM Cannabis Corp. (das “Unternehmen” oder “IM Cannabis”) (CSE: IMCC, NASDAQ: IMCC), ein globales Cannabisunternehmen mit Niederlassungen in Israel, Kanada und Deutschland, freut sich, Pläne bekannt zu geben, seine beliebte…
- Press releases
IM Cannabis To Launch WAGNERS Brand In Germany
IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis market IM Cannabis Corp. (the “Company” or “IM Cannabis”) (CSE: IMCC, NASDAQ: IMCC), a global cannabis company with operations in Israel, Canada, and Germany is pleased to announce plans to launch its popular Canadian WAGNERS brand in…
- CBD Market
Cellular Goods Appoints New CEO As It Launches First Products Following £3m Loss
CELLULAR Goods has announced that health and beauty industry veteran Anna Chokina has replaced Alexis Abraham as its new CEO with immediate effect.
- Adult-Use
SAFE banking left out of congressional defense bill
Senate Democrats are leading the charge to drop cannabis banking reform from the latest iteration of the National Defense Authorization Act (NDAA), according to the News Station.
- Your #1 Podcast on Cannabis News
The current state of cannabis insurance right now
Business of Cannabis was the Platinum Media Partner for the Lift&Co.
